Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy.
Gillini LA, Cingolani A, Murri R, De Luca A, Di Giambenedetto S, Wu A, Cauda R, Chaisson RE. Gillini LA, et al. Among authors: murri r. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):546-7. doi: 10.1097/00126334-200204150-00018. J Acquir Immune Defic Syndr. 2002. PMID: 11981374 No abstract available.
Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.
Starace F, Ammassari A, Trotta MP, Murri R, De Longis P, Izzo C, Scalzini A, d'Arminio Monforte A, Wu AW, Antinori A; AdICoNA Study Group. NeuroICoNA Study Group. Starace F, et al. Among authors: murri r. J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S136-9. doi: 10.1097/00126334-200212153-00010. J Acquir Immune Defic Syndr. 2002. PMID: 12562037 Review.
Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.
De Luca A, Cingolani A, Di Giambenedetto S, Trotta MP, Baldini F, Rizzo MG, Bertoli A, Liuzzi G, Narciso P, Murri R, Ammassari A, Perno CF, Antinori A. De Luca A, et al. Among authors: murri r. J Infect Dis. 2003 Jun 15;187(12):1934-43. doi: 10.1086/375355. Epub 2003 May 22. J Infect Dis. 2003. PMID: 12792870 Clinical Trial.
Neurocognitive performance and quality of life in patients with HIV infection.
Tozzi V, Balestra P, Galgani S, Murri R, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Costa M, Sampaolesi A, Fantoni M, Noto P, Ippolito G, Wu AW. Tozzi V, et al. Among authors: murri r. AIDS Res Hum Retroviruses. 2003 Aug;19(8):643-52. doi: 10.1089/088922203322280856. AIDS Res Hum Retroviruses. 2003. PMID: 13678465
Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART.
Antinori A, Cozzi-Lepri A, Ammassari A, Trotta MP, Nauwelaers D, Hoetelmans R, Murri R, Melzi S, Narciso P, Nasta P, Zaccarelli M, Santopadre P, Vecchiet J, Izzo CM, Maonforte Ad; AdICoNA Study Group. Antinori A, et al. Among authors: murri r. Antivir Ther. 2004 Apr;9(2):291-6. Antivir Ther. 2004. PMID: 15134192 Clinical Trial.
253 results